Home

Da Volterra,
Leader in Microbiome Protection for Cancer Patients

MORE

Home

Our vision

A HEALTHY MICROBIOME

Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field.

Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiome to prevent and cure life-threatening diseases.

We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.

Our most advanced product

DAV132

DAV132 is a novel colon-targeted adsorbent developed to prevent antibiotic-induced dysbiosis. It has already undergone multiple clinical trials, including a multicenter phase 2 study in Europe. It has been developed using in-house expertise on gut microbiome, drug delivery technologies and antibiotics.

more